Markku Voutilainen
Chief physician, Department of Gastroenterology; professor in gastroenterology
markku.voutilainen@utu.fi ORCID identifier: https://orcid.org/https://orcid.org/0000-0002-3304-1680 |
Areas of expertise
Gastroenterology
Gastroenterology
Publications
- The impact of IBD on ability to work and study: a patient perspective (2025)
- Scandinavian Journal of Gastroenterology
(A1 Refereed original research article in a scientific journal) - Costs of medications used to treat inflammatory bowel disease (2024)
- Scandinavian Journal of Gastroenterology
(A1 Refereed original research article in a scientific journal) - Effect of inflammatory bowel diseases on household chores (2023)
- JGH Open
(A1 Refereed original research article in a scientific journal) - Keratin 7 expression in different anatomical parts of colonic epithelium in inflammatory bowel diseases and its prognostic value: a 3-year follow-up study (2023)
- Scientific Reports
(A1 Refereed original research article in a scientific journal) - Maksansiirtopotilailla on hyvä pitkän aikavälin ennuste Varsinais-Suomessa (2023)
- Lääkärilehti
(A1 Refereed original research article in a scientific journal) - Colonocyte keratin 7 is expressed de novo in inflammatory bowel diseases and associated with pathological changes and drug-resistance (2022)
- Scientific Reports
(A1 Refereed original research article in a scientific journal) - Dose-escalation of adalimumab, golimumab or ustekinumab in inflammatory bowel diseases: characterization and implications in real-life clinical practice (2022)
- Scandinavian Journal of Gastroenterology
(A1 Refereed original research article in a scientific journal) - Inflammatory bowel disease: perceived impact on leisure-time activities (2022)
- Scandinavian Journal of Gastroenterology
(A1 Refereed original research article in a scientific journal) - Keratiinit suoliston epiteelisoluissa ja paksusuolisyövän analytiikassa (2022)
- Duodecim
(A2 Refereed review article in a scientific journal ) - Therapeutic management and outcomes in inflammatory bowel diseases, 2010 to 2017 in cohorts from Denmark, Sweden and Norway (2022)
- Alimentary Pharmacology and Therapeutics
(A1 Refereed original research article in a scientific journal)



